Free Submission Public Relations &
Deutsch English


Free Research Reports on ARNA, AUQ, MCP and NLY Issued by the Bedford Report Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

Print article Print article
© Marketwire 2013
2013-03-27 13:46:57 -

NEW YORK, NY -- (Marketwire) -- 03/27/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares have soared over 230 percent in the past year. The company's anti-obesity drug, BELVIQ, was the first one to be approved by the FDA in over a decade. Once the US Drug Enforcement Administration finalizes the scheduling designation BELVIQ will be available to eligible patients in the United States by prescription.

Find out more about Arena Pharmaceuticals including full access to the free equity report at: :

AuRico Gold Inc. (NYSE: AUQ) shares declined 7.68 percent on more than double the average daily volume Tuesday to close at $6.13 a share. The company reported revenues of $63.1 million for the fourth quarter of 2012, a decrease of 40.81 percent when compared to the year ago quarter.

Find out more about AuRico Gold including full access to the free equity report at: :

Molycorp Inc. (NYSE: MCP) shares dropped 5.64 percent on volume of over 10 million shares traded Tuesday to close at $5.35 a share. The company reported a loss attributable to common stockholders of $460.9 million, or a loss of $4.31 per share for the full year 2012. Shares of Molycorp have plunged over 40 percent year-to-date.

Find out more about Molycorp including full access to the free equity report at: :

Annaly Capital Management, Inc. (NYSE: NLY) shares have gained approximately 15 percent year-to-date. The company currently offers investors an annual dividend of $1.80 a share for a dividend yield of roughly 11.20 percent. The company is expected to release first quarter 2013 results on April 29th, 2013.

Find out more about Annaly Capital Management including full access to the free equity report at: :

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact :

Press Information:

Contact Person:

Disclaimer: (c) 2014 Market Wire. All of the press releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Market Wire's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact